Admin Suppl to examine the role of Vit E Acetate in ENDS

行政补充检查维生素 E 醋酸酯在 ENDS 中的作用

基本信息

  • 批准号:
    10060130
  • 负责人:
  • 金额:
    $ 21.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

Electronic cigarettes (ecigs) gained popularity in never- and active-smokers who are persuaded by intense ad campaigns that brands their use as a healthy alternative to cigarette smoke. Whether heated vaporized contents in ecigs, e.g., propylene glycol (PG), vegetable glycerol (VG) with or without nicotine, are safe alternatives to cigarette smoking remains unknown. We have developed a robust mouse model of conventional and ecig exposure and made several novel discoveries that provide unique insights into the toxicology of ecig in the lungs. In the first year of our funding, we have shown that the popular ecig solvents (e.g., 60/40 ratio of PG/VG), independent of nicotine, can alter lung lipid homeostasis and disrupt the function of alveolar macrophages and epithelial cells (Madison et al, JCI, 2019). We showed that ecig exposure can result in increased abundance of endogenous lipid species normally found in the lung lining fluid, but surfactant proteins (SP)-A, and SP-D associated with these lipids are significantly reduced. Several recent reports have described sporadic cases of ecig (nicotine, and/or cannabis) users who presented with a mysterious (non-infectious) type of lipoid pneumonia. These respiratory illnesses are clinically characterized by dyspnea, fatigue, and in most severe form, respiratory failure and death. Currently the causative factor(s) for the acute respiratory failure in ecig users remains unknown, however the FDA reported that over ½ of the ecig liquid samples linked to the hospitalized patients tested positive for Vitamin E (Vit E) acetate. In this supplemental application, we request funding to examine the acute and chronic effects of Vit E acetate inhalation to determine whether they play a causative role in lung toxicity. We propose the following two Specific Aims: Aim 1. To determine the effect of acute and chronic inhalational exposure to Vitamin E acetate in mice. We have found that independent of nicotine, lung surfactant composition in mice exposed to chronic ecig is altered. The cannabis-containing ecig liquid used by a number of patients who presented with acute respiratory failure, contains Vit E acetate, a common solvent used in dermatological products. Using our well established ecig model, we will determine if acute (two weeks) or chronic (two months) exposure to Vit E acetate alone or in combination with PG/VG can alter surfactant in the lungs. Aim 2. To determine whether acute or chronic inhalation of Vitamin E acetate alters the function of macrophages and/or epithelial cells in the lungs. A common clinical feature of reported cases in several hundred ecig users who have presented with respiratory failure, is the diagnosis of lipoid pneumonia which is characterized by the presence of abnormal lung macrophages that contain large amounts of intracytoplasmic lipids. Given that Vit E acetate, has been found in ecig products used by over half of the cases associated with severe respiratory disease, we hypothesize that it can synergize with the common solvents in ecig to induce cellular toxicity in lung immune and or epithelial cells.
电子香烟(ecigs)在从不吸烟和经常吸烟的人中越来越受欢迎,他们被强烈的广告所说服。 宣传活动将其作为香烟烟雾的健康替代品。加热蒸发的内容物是否在 电子烟,例如,丙二醇(PG),植物甘油(VG),含或不含尼古丁,是安全的替代品, 吸烟仍然是未知的。我们已经开发了一个强大的小鼠模型的常规和ecig暴露 并取得了一些新的发现,为肺中ecig的毒理学提供了独特的见解。在 在我们资助的第一年,我们已经表明流行的CIG溶剂(例如,PG/VG的60/40比率),独立 尼古丁,可以改变肺脂质稳态,破坏肺泡巨噬细胞和上皮细胞的功能 (麦迪逊等人,JCI,2019)。我们发现暴露于ecig可导致内源性脂质丰度增加 通常在肺衬里液中发现的物质,但表面活性蛋白(SP)-A和SP-D与这些物质相关。 脂质显著减少。最近的几份报告描述了ecig(尼古丁和/或 大麻)用户谁提出了一个神秘的(非传染性)类型的类脂肺炎。这些呼吸 疾病的临床特征是呼吸困难、疲劳,最严重的形式是呼吸衰竭和死亡。 目前,引起ecig使用者急性呼吸衰竭的原因尚不清楚, FDA报告说,与住院患者有关的ecig液体样本中有一半以上的维生素检测呈阳性。 E(维生素E)乙酸酯。在这份补充申请中,我们要求资助研究急性和慢性影响, 醋酸维生素E吸入,以确定它们是否在肺毒性中发挥致病作用。我们建议 有两个具体目标:目标1。确定急性和慢性吸入暴露对 维生素E醋酸酯。我们已经发现,独立于尼古丁,小鼠肺表面活性物质的组成 暴露于慢性EIG的人改变了。一些病人使用的含有大麻的ecig液体, 含有维生素E醋酸酯,一种用于皮肤科产品的常见溶剂。使用 我们建立了良好的ecig模型,我们将确定是否急性(两周)或慢性(两个月)暴露于维生素 E醋酸盐单独或与PG/VG组合可改变肺中的表面活性剂。目标2.以确定是否 急性或慢性吸入维生素E醋酸酯改变巨噬细胞和/或上皮细胞的功能 在肺部。在数百名出现以下症状的ecig使用者中报告的病例的一个共同临床特征是 呼吸衰竭是类脂性肺炎的诊断,其特征在于存在异常肺 含有大量胞浆内脂质的巨噬细胞。鉴于维生素E醋酸酯,已被发现在 超过一半的严重呼吸道疾病病例使用了ecig产品,我们假设它可以 与CIG中的常用溶剂协同作用,以诱导肺免疫细胞和/或上皮细胞的细胞毒性。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intermittent Hypoxia and Effects on Early Learning/Memory: Exploring the Hippocampal Cellular Effects of Pediatric Obstructive Sleep Apnea.
  • DOI:
    10.1213/ane.0000000000005273
  • 发表时间:
    2021-07-01
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Chandrakantan A;Adler AC;Tohsun M;Kheradamand F;Ray RS;Roth S
  • 通讯作者:
    Roth S
Extracellular matrix in lung development, homeostasis and disease.
  • DOI:
    10.1016/j.matbio.2018.03.005
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zhou Y;Horowitz JC;Naba A;Ambalavanan N;Atabai K;Balestrini J;Bitterman PB;Corley RA;Ding BS;Engler AJ;Hansen KC;Hagood JS;Kheradmand F;Lin QS;Neptune E;Niklason L;Ortiz LA;Parks WC;Tschumperlin DJ;White ES;Chapman HA;Thannickal VJ
  • 通讯作者:
    Thannickal VJ
Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association.
青少年吸电子烟对心肺的影响:美国心脏协会的科学声明。
  • DOI:
    10.1161/res.0000000000000544
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    20.1
  • 作者:
    Wold,LorenE;Tarran,Robert;CrottyAlexander,LauraE;Hamburg,NaomiM;Kheradmand,Farrah;StHelen,Gideon;Wu,JosephC;AmericanHeartAssociationCouncilonBasicCardiovascularSciences;CouncilonArteriosclerosis,ThrombosisandVascularBiolo
  • 通讯作者:
    CouncilonArteriosclerosis,ThrombosisandVascularBiolo
Laryngeal inflammatory response to smoke and vape in a murine model.
小鼠模型中对烟雾和电子烟的喉部炎症反应。
  • DOI:
    10.1016/j.amjoto.2018.10.001
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Ha,Tu-AnhN;Madison,MatthewC;Kheradmand,Farrah;Altman,KennethW
  • 通讯作者:
    Altman,KennethW
Matrix remodeling in chronic lung diseases.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Farrah Kheradmand其他文献

Farrah Kheradmand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Farrah Kheradmand', 18)}}的其他基金

CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
CMA:与部署相关的颗粒物暴露对肺部和全身的影响
  • 批准号:
    10383650
  • 财政年份:
    2020
  • 资助金额:
    $ 21.2万
  • 项目类别:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
CMA:与部署相关的颗粒物暴露对肺部和全身的影响
  • 批准号:
    9774557
  • 财政年份:
    2020
  • 资助金额:
    $ 21.2万
  • 项目类别:
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
CMA:与部署相关的颗粒物暴露对肺部和全身的影响
  • 批准号:
    10553621
  • 财政年份:
    2020
  • 资助金额:
    $ 21.2万
  • 项目类别:
Toxic Effects of Ecigs Following Transition From Conventional Cigarettes
从传统香烟过渡到电子烟后的毒性作用
  • 批准号:
    9982334
  • 财政年份:
    2018
  • 资助金额:
    $ 21.2万
  • 项目类别:
Ancillary T Cell Based Studies in SPIROMICS
基于 SPIROMICS 的辅助 T 细胞研究
  • 批准号:
    8266804
  • 财政年份:
    2012
  • 资助金额:
    $ 21.2万
  • 项目类别:
Ancillary T Cell Based Studies in SPIROMICS
基于 SPIROMICS 的辅助 T 细胞研究
  • 批准号:
    8794458
  • 财政年份:
    2012
  • 资助金额:
    $ 21.2万
  • 项目类别:
Ancillary T Cell Based Studies in SPIROMICS
基于 SPIROMICS 的辅助 T 细胞研究
  • 批准号:
    8604407
  • 财政年份:
    2012
  • 资助金额:
    $ 21.2万
  • 项目类别:
Ancillary T Cell Based Studies in SPIROMICS
基于 SPIROMICS 的辅助 T 细胞研究
  • 批准号:
    8424239
  • 财政年份:
    2012
  • 资助金额:
    $ 21.2万
  • 项目类别:
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
COPD 恶化方案中病毒诱导的 T 细胞反应:LES COPD
  • 批准号:
    8356768
  • 财政年份:
    2010
  • 资助金额:
    $ 21.2万
  • 项目类别:
Regulation of Innate and Adaptive Immunity in Human COPD and Emphysema
人类慢性阻塞性肺病和肺气肿的先天性和适应性免疫的调节
  • 批准号:
    8195974
  • 财政年份:
    2009
  • 资助金额:
    $ 21.2万
  • 项目类别:

相似海外基金

Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
  • 批准号:
    10633823
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
  • 批准号:
    10724042
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
  • 批准号:
    10739060
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
  • 批准号:
    10731311
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
  • 批准号:
    10734357
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Respiratory Drive in Acute Respiratory Failure
急性呼吸衰竭中的呼吸驱动
  • 批准号:
    10637245
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
  • 批准号:
    10732929
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
  • 批准号:
    10622756
  • 财政年份:
    2023
  • 资助金额:
    $ 21.2万
  • 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
  • 批准号:
    10413457
  • 财政年份:
    2022
  • 资助金额:
    $ 21.2万
  • 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
  • 批准号:
    10313769
  • 财政年份:
    2022
  • 资助金额:
    $ 21.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了